Trade

Titan Biotech share price

Extreme risk
  • 71%Low risk
  • 71%Moderate risk
  • 71%Balanced risk
  • 71%High risk
  • 71%Extreme risk
  • 444.00(0.40%)
    June 5, 2026 15:25:52 PM IST
    • NSE
    • BSE
  • Vol : 37.04 K (NSE + BSE)
    Last 20 day avg : 28.91 K

Titan Biotech is trading 0.40% upper at Rs 444.00 as compared to its last closing price. Titan Biotech has been trading in the price range of 458.00 & 425.10. Titan Biotech has given 109.84% in this year & -2.15% in the last 5 days. Titan Biotech has TTM P/E ratio 63.27 as compared to the sector P/E of 32.49.The company posted a net profit of 6.73 Crores in its last quarter.Listed peers of Titan Biotech include Sun Pharmaceutical Industries (0.48%), Divi's Laboratories (0.47%), Torrent Pharmaceuticals (2.07%).The Mutual Fund holding in Titan Biotech was at -% in . The MF holding has - from the last quarter. The FII holding in Titan Biotech was at -% in . The FII holding has - from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jun 06, 2026, 05:18 AM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    -1.05
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.03
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.11
    Lower than industry
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    10.07
    Higher than historical values
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    61.13
    Higher than historical values
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    9.65
    Indicates overvaluation
Price range
Day Range
Lowest
425.10
Highest
458.00
52 week range
Lowest
74.73
Highest
555.65
Titan Biotech Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Sun Pharmaceutical Industries
Neutral
1,787.950.484,29,206.8535.985.73--
Divi's Laboratories
Neutral
6,625.450.471,76,150.1276.0311.14--
Torrent Pharmaceuticals
Bullish
4,427.502.071,49,823.5573.9318.77--
Cipla
Moderately Bullish
1,400.700.211,13,239.2120.703.49--
Dr Reddy's Laboratories
Neutral
1,277.800.851,06,647.4818.843.18--
Titan Biotech Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2026-05-30Audited Results & Final Dividend
2026-02-12Quarterly Results
2025-11-29Stock Split
2025-11-11Quarterly Results
2025-08-13Quarterly Results
About the company Titan Biotech
  • IndustryBiotechnology & Drugs
  • ISININE150C01029
  • BSE Code524717
  • NSE Code
Titan Biotech Limited is an India-based manufacturer and exporter of biological products. The Company is a manufacturer of clinically approved collagen (fish, bovine, and chicken), skin care ingredients, bone and joint care ingredients, proteins, animal nutrition ingredients and many more. It can provide any microbiology product that its customers need from powder culture media to prepared media. Its product categories include food ingredients, collagen and proteins, pharmaceuticals and nutraceuticals, animal nutrition, probiotics and fermentation ingredients, agriculture products, and culture media. The Company's food ingredients include flavoring and food preservative and improvers. Its collagen and proteins include wheat protein hydrolysate and collagen peptides. Its nutraceuticals include milk protein and bovine cartilage extract. Its animal nutrition includes binding agent, chelates minerals and yeast. Its agriculture products include bio fungicide, insecticides and acaricides.
  • Management Info
  • Prem GuptaChief Financial Officer
  • Charanjit SinghCompliance Officer, Company Secretary
  • Shivom SinglaVice President - Bulk Division, Whole Time Director
  • Udit SinglaVice President - Media Division, Whole Time Director
  • Naresh SinglaManaging Director, Executive Director
  • Suresh SinglaManaging Director, Executive Director
  • Raja SinglaWhole-Time Director
Titan Biotech Share Price FAQs

Titan Biotech is trading at 444.00 as on Fri Jun 05 2026 09:55:52. This is 0.40% upper as compared to its previous closing price of 442.25.

The market capitalization of Titan Biotech is 1834.54 Cr as on Fri Jun 05 2026 09:55:52.

The 52 wk high for Titan Biotech is 555.65 whereas the 52 wk low is 74.73

Titan Biotech can be analyzed on the following key metrics -

  • TTM P/E: 63.27
  • Sector P/E: 32.49
  • Dividend Yield: 0.11%
  • D/E ratio: 0.03

Titan Biotech reported a net profit of 29.89 Cr in 2026.